Myelodysplastic syndromes trials in India

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  Where

  Ahmedabad, Delhi, Ernākulam, Ghaziabad, Gūrgaon, Kolkata, Ludhiana, Mumbai, New Delhi, Vellore

  Age

  18 years and over

  People

  225 worldwide

  Run by

  Takeda

  See details and how to joinNCT06499285 · EU 2024-516009-22-00
• Phase 3Taking people
  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  Where

  Chandigarh, Delhi, Hyderabad, Kochi, Pune, Vellore

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Takeda

  See details and how to joinNCT07422480 · EU 2025-523544-12-00